Molecular mechanisms of congenital heart block |
| |
Authors: | Aurélie Ambrosi Sven-Erik Sonesson Marie Wahren-Herlenius |
| |
Institution: | 1. Unit of Experimental Rheumatology, Department of Medicine, Karolinska Institutet, 171 76 Stockholm, Sweden;2. Department of Women and Child Health, Karolinska Institutet, 171 76 Stockholm, Sweden |
| |
Abstract: | Autoantibody-associated congenital heart block (CHB) is a passively acquired autoimmune condition associated with maternal anti-Ro/SSA antibodies and primarily affecting electric signal conduction at the atrioventricular node in the fetal heart. CHB occurs in 1–2% of anti-Ro/SSA antibody-positive pregancies and has a recurrence rate of 12–20% in a subsequent pregnancy. Despite the long-recognized association between maternal anti-Ro/SSA autoantibodies and CHB, the molecular mechanisms underlying CHB pathogenesis are not fully understood, but several targets for the maternal autoantibodies in the fetal heart have been suggested. Recent studies also indicate that fetal susceptibility genes determine whether an autoantibody-exposed fetus will develop CHB or not, and begin to identify such genes. In this article, we review the different lines of investigation undertaken to elucidate the molecular pathways involved in CHB development and reflect on the hypotheses put forward to explain CHB pathogenesis as well as on the questions left unanswered and that should guide future studies. |
| |
Keywords: | Congenital heart block Atrioventricular block Neonatal lupus erythematosus Autoantibodies Ro/SSA La/SSB MHC |
本文献已被 ScienceDirect 等数据库收录! |
|